![Biomedicines | Free Full-Text | Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat Biomedicines | Free Full-Text | Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat](https://pub.mdpi-res.com/biomedicines/biomedicines-09-00313/article_deploy/html/images/biomedicines-09-00313-ag.png?1617783328)
Biomedicines | Free Full-Text | Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
![Janssen Announces U.S. FDA Approval of SYMTUZA™ (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection Janssen Announces U.S. FDA Approval of SYMTUZA™ (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection](https://mma.prnewswire.com/media/719742/Product_Bottle.jpg?p=twitter)
Janssen Announces U.S. FDA Approval of SYMTUZA™ (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
![DARUNAVIR+RITONAVIR: Learn About DARUNAVIR+RITONAVIR Uses, Dosage, Side-Effects, Warnings on PharmEasy DARUNAVIR+RITONAVIR: Learn About DARUNAVIR+RITONAVIR Uses, Dosage, Side-Effects, Warnings on PharmEasy](https://cdn01.pharmeasy.in/dam/products/N87128/durart-r-450mg-bottle-of-60-tablets-4-1641205126.jpg)